These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8055238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A, Seksik P, Chrétien Y, Corphechot C, Poupon R, Poupon RE, Chazouillères O.
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [Abstract] [Full Text] [Related]

  • 5. Management of primary sclerosing cholangitis.
    Björnsson E.
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A, Glaumann H, Persson B, Broomé U.
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [Abstract] [Full Text] [Related]

  • 7. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
    van Milligen de Wit AW, van Deventer SJ, Tytgat GN.
    Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
    [Abstract] [Full Text] [Related]

  • 8. Hepatobiliary disease in inflammatory bowel disease.
    Balan V, LaRusso NF.
    Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
    [Abstract] [Full Text] [Related]

  • 9. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
    Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G.
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
    [Abstract] [Full Text] [Related]

  • 10. Primary sclerosing cholangitis.
    Rodriguez HJ, Bass NM.
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC.
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [Abstract] [Full Text] [Related]

  • 12. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M, Elinav H, Goldin E, Ilan Y.
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH.
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [Abstract] [Full Text] [Related]

  • 14. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden.
    Bergquist A, Said K, Broomé U.
    Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768
    [Abstract] [Full Text] [Related]

  • 15. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H.
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [Abstract] [Full Text] [Related]

  • 16. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP.
    J Hepatol; 2008 Jan; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [Abstract] [Full Text] [Related]

  • 17. Primary sclerosing cholangitis: summary of a workshop.
    LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH.
    Hepatology; 2006 Sep; 44(3):746-64. PubMed ID: 16941705
    [Abstract] [Full Text] [Related]

  • 18. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G, Riva S, Sciveres M.
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [Abstract] [Full Text] [Related]

  • 19. [MRCP in primary sclerosing cholangitis].
    Weber C, Krupski G, Lorenzen J, Grotelüschen R, Seitz U, Rogiers X, Adam G.
    Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620
    [Abstract] [Full Text] [Related]

  • 20. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
    Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD.
    Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.